Preliminary studies suggest conolidine could inhibit distinct ion channels, minimizing neuronal excitability and limiting discomfort alerts. This system is particularly suitable in neuropathic discomfort, in which abnormal signaling leads to persistent irritation. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR) pathways